Amrutanjan Health Care Limited has reported Standalone financial results for the period ended March 31, 2026.
Financial Results (Q4 FY2026) - QoQ Comparison
The company has reported total income of Rs. 154.4987 crores during the period ended March 31, 2026 as compared to Rs. 145.1583 crores during the period ended December 31, 2025.
The company has posted net profit / (loss) of Rs. 16.1928 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs. 19.4522 crores for the period ended December 31, 2025.
The company has reported EPS of Rs. 5.60 for the period ended March 31, 2026 as compared to Rs. 6.73 for the period ended December 31, 2025.
| Total Income | ₹ 154.4987 crs | ₹145.1583 crs | 6.43% |
| Net Profit | ₹16.1928 crs | ₹19.4522 crs | -16.76% |
| EPS | ₹5.60 | ₹6.73 | -16.79% |
Financial Results (Q4 FY2026) - YoY Comparison The company has reported total income of Rs. 154.4987 crores during the period ended March 31, 2026 as compared to Rs.140.2329 crores during the period ended March 31, 2025.
The company has posted net profit / (loss) of Rs.16.1928 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs.15.1778 crores for the period ended March 31, 2025.
The company has reported EPS of Rs.5.60 for the period ended March 31, 2026 as compared to Rs.5.25 for the period ended March 31, 2025.
| Total Income | ₹ 154.4987 crs | ₹140.2329 crs | 10.17% |
| Net Profit | ₹16.1928 crs | ₹15.1778 crs | 6.69% |
| EPS | ₹5.60 | ₹5.25 | 6.67% |
Financial Results (Year Ended FY2026) - YoY Comparison The company has reported total income of Rs.520.1266 crores during the Financial Year ended March 31, 2026 as compared to Rs.469.4950 crores during the Financial Year ended March 31, 2025.
The company has posted net profit / (loss) of Rs.57.9178 crores for the Financial Year ended March 31, 2026 as against net profit / (loss) of Rs.50.8347 crores for the Financial Year ended March 31, 2025.
The company has reported EPS of Rs.20.03 for the Financial Year ended March 31, 2026 as compared to Rs.17.58 for the Financial Year ended March 31, 2025.
| Total Income | ₹520.1266 crs | ₹469.4950 crs | 10.78% |
| Net Profit | ₹57.9178 crs | ₹50.8347 crs | 13.93% |
| EPS | ₹20.03 | ₹17.58 | 13.94% |
Shares of Amrutanjan Health Care Limited was last trading in BSE at Rs. 548.80 as compared to the previous close of Rs. 558.60. The total number of shares traded during the day was 1639 in over 287 trades.
The stock hit an intraday high of Rs. 568.50 and intraday low of 542.90. The net turnover during the day was Rs. 913053.00.
Source : Equity Bulls
Keywords
AmrutanjanHealthCare
Q4FY26
Q4FY2026
FY26
FY2026
ResultUpdate